Glenn Whiteside

474 total citations
7 papers, 389 citations indexed

About

Glenn Whiteside is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Glenn Whiteside has authored 7 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Immunology and 1 paper in Surgery. Recurrent topics in Glenn Whiteside's work include Cancer therapeutics and mechanisms (1 paper), Microbial Metabolites in Food Biotechnology (1 paper) and Congenital gastrointestinal and neural anomalies (1 paper). Glenn Whiteside is often cited by papers focused on Cancer therapeutics and mechanisms (1 paper), Microbial Metabolites in Food Biotechnology (1 paper) and Congenital gastrointestinal and neural anomalies (1 paper). Glenn Whiteside collaborates with scholars based in New Zealand and Germany. Glenn Whiteside's co-authors include Caroline Perry, Fiona Cameron, Kate McKeage, Fiona Cameron, Karen M. Holdaway, Lynnette R. Ferguson, Bruce C. Baguley and Atkins Rc and has published in prestigious journals such as Drugs, Environmental and Molecular Mutagenesis and PubMed.

In The Last Decade

Glenn Whiteside

7 papers receiving 381 citations

Peers

Glenn Whiteside
Yoshikazu Kuboi Japan
Stefan A. Cohen United States
Rebecca E. Parker United States
Diana Beyer Germany
Jau‐Chen Lin Taiwan
Takayuki Kojima Japan
P Ross United States
D. Bae United States
M.J. Tilby United Kingdom
C S Johnson United States
Yoshikazu Kuboi Japan
Glenn Whiteside
Citations per year, relative to Glenn Whiteside Glenn Whiteside (= 1×) peers Yoshikazu Kuboi

Countries citing papers authored by Glenn Whiteside

Since Specialization
Citations

This map shows the geographic impact of Glenn Whiteside's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenn Whiteside with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenn Whiteside more than expected).

Fields of papers citing papers by Glenn Whiteside

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glenn Whiteside. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenn Whiteside. The network helps show where Glenn Whiteside may publish in the future.

Co-authorship network of co-authors of Glenn Whiteside

This figure shows the co-authorship network connecting the top 25 collaborators of Glenn Whiteside. A scholar is included among the top collaborators of Glenn Whiteside based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glenn Whiteside. Glenn Whiteside is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Cameron, Fiona, Glenn Whiteside, & Kate McKeage. (2012). Phentermine and Topiramate Extended Release (Qsymia™). Drugs. 72(15). 2033–2042. 21 indexed citations
2.
Whiteside, Glenn, et al.. (2012). Linaclotide. Drugs. 72(16). 2167–2175. 18 indexed citations
3.
Whiteside, Glenn, et al.. (2012). Mogamulizumab. Drugs. 72(9). 1293–1298. 74 indexed citations
4.
Cameron, Fiona, Glenn Whiteside, & Caroline Perry. (2011). Ipilimumab. Drugs. 71(8). 1093–1104. 172 indexed citations
5.
Whiteside, Glenn, et al.. (2011). Vandetanib. Drugs. 71(10). 1355–1365. 79 indexed citations
6.
Ferguson, Lynnette R., Glenn Whiteside, Karen M. Holdaway, & Bruce C. Baguley. (1996). Application of fluorescence in situ hybridisation to study the relationship between cytotoxicity, chromosome aberrations, and changes in chromosome number after treatment with the topoisomerase II inhibitor amsacrine. Environmental and Molecular Mutagenesis. 27(4). 255–262. 18 indexed citations
7.
Whiteside, Glenn, et al.. (1979). Continuous ambulatory peritoneal dialysis (CAPD) in the treatment of end-stage renal failure.. PubMed. 16. 171–7. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshikazu Kuboi Breakdown of academic impact, for papers by Stefan A. Cohen Breakdown of academic impact, for papers by Rebecca E. Parker Breakdown of academic impact, for papers by Diana Beyer Breakdown of academic impact, for papers by Jau‐Chen Lin Breakdown of academic impact, for papers by Takayuki Kojima Breakdown of academic impact, for papers by P Ross Breakdown of academic impact, for papers by D. Bae Breakdown of academic impact, for papers by M.J. Tilby Breakdown of academic impact, for papers by C S Johnson
Rankless by CCL
2026